Proud Sponsor of the Organization of Women in International Trade - Badge

Articles Posted in Merger Highlights

DOJ Antitrust Division Dismisses Suit Against Amex GBT Merger On Eve of Trial
Doyle, Barlow & Mazard PLLC

The U.S. Department of Justice (DOJ) Antitrust Division, under the Biden administration, filed a civil antitrust lawsuit on January 10, 2025, to block American Express Global Business Travel’s (Amex GBT) $570 million acquisition of CWT Holdings LLC. The case was dismissed by the DOJ in July 2025, just before a scheduled trial in September 2025,…

Continue reading ›
Washington and Colorado Are the First Two States to Require Pre-Merger Notifications
Doyle, Barlow & Mazard PLLC

If your company is filing a premerger notification form with the Department of Justice and Federal Trade Commission, do not forget to simultaneously file with relevant states that have enacted premerger notification laws. The first two states to enact these laws are Washington and Colorado. Washington Premerger Notification Law As of July 27, 2025, federal…

Continue reading ›
DOJ Settles HPE/Juniper Networks Avoiding Trial
Doyle, Barlow & Mazard PLLC

The U.S. Department of Justice (DOJ) reached a settlement with Hewlett Packard Enterprise (HPE) and Juniper Networks on June 28, 2025, resolving concerns over HPE’s $14 billion acquisition of Juniper Networks. The settlement required HPE to divest its Instant On wireless networking business and license Juniper’s Mist AI software source code to independent competitors to…

Continue reading ›
A Return to Merger Remedies: Trump Administration Shifts Antitrust Policy
Doyle, Barlow & Mazard PLLC

Introduction Under the Biden administration, U.S. antitrust agencies, particularly the Department of Justice Antitrust Division (DOJ) and the Federal Trade Commission (FTC), took a hardline stance against negotiated merger remedies. Instead of settling, they often challenged mergers outright or allowed deals to close without formal conditions, expressing doubts about the effectiveness of remedies like structural…

Continue reading ›
Trump DOJ Should Reevaluate HPE’s Acquisition of Juniper: A Case for Competition and National Security
Doyle, Barlow & Mazard PLLC

The Department of Justice’s (DOJ) decision to challenge Hewlett Packard Enterprise’s (HPE) $14 billion acquisition of Juniper Networks is misguided and threatens innovation and U.S. competitiveness.  Gail Slater, the newly confirmed Assistant Attorney General for the DOJ’s Antitrust Division, should reconsider this decision and assess its broader implications for competition, innovation, and national interests. Facing…

Continue reading ›
7-Eleven Closes Speedway Deal at its Own Risk
Doyle, Barlow & Mazard PLLC

7 Eleven and Speedway  announced the transaction in August 2020.  The FTC issued Second Requests for information to the parties and investigated the transaction because it raised a number of competitive concerns in various local geographic markets.  The parties negotiated a divestiture of approximately 300 stores with the FTC staff to remedy the antitrust concerns. …

Continue reading ›
FTC Approves El Dorado’s Acquisition of Caesar’s With Strong Dissent From Commissioner Chopra
Doyle, Barlow & Mazard PLLC

On June 26, 2020, the Federal Trade Commission (“FTC”) entered into a settlement agreement that allowed Eldorado Resorts, Inc. (“Eldorado”) to acquire Caesars Entertainment Corporation (“Caesars”) for $17.3 billion. Background Eldorado agreed to acquire Caesars for $17.3 billion on June 24, 2019. Eldorado is a provider of casino entertainment and hospitality services, operating 23 casino…

Continue reading ›
Deeply Divided FTC Approves AbbVie’s Acquisition of Allergan
Doyle, Barlow & Mazard PLLC

On May 5, 2020, the FTC approved AbbVie Inc.’s (“AbbVie”) $63 billion acquisition of Allergan plc (“Allergan”) on the condition that the merging parties divest three minor products.  The consent agreement was approved by a 3-2 party line vote. The FTC has a long history of scrutinizing transactions in the pharmaceutical industry, but Commissioners’ statements demonstrate that they are not on…

Continue reading ›
Consumer Groups Raise Rebate Wall Concerns With Regards to AbbVie/Allergan Merger
Doyle, Barlow & Mazard PLLC

On February 18, 2020, a group of unions, consumer groups, and public interest organizations filed a letter with the U.S. Federal Trade Commission (“FTC”) raising concerns that the divestiture of Allergan plc’s (“Allergan”) pipeline drug, brazikumab, will not succeed unless the FTC addresses AbbVie’s use of rebate walls. Consumer Group Concerns Regarding Rebate Walls and…

Continue reading ›
Can Deals That Do Not Trigger an HSR Filing Raise Antitrust Concerns? Yes, Buyer and Sellers Beware!
Doyle, Barlow & Mazard PLLC

The federal antitrust agencies continue their emphasis on investigating, challenging, and unwinding consummated transactions that are not reportable under the Hart Scott Rodino (“HSR”) Act. Most recently, on November 6, 2019, the Federal Trade Commission (“FTC”) issued an Opinion and Final Order in which the Commission upheld the Administrative Law Judge’s (“ALJ”) decision that Otto…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.